Wearable Devices for Patient Monitoring in Long QT Syndrome

Queen Mary University of London80 enrolled

Overview

The main research question of this study is whether wearable devices have utility in monitoring patients with Long QT syndrome.

Study Type

OBSERVATIONAL

Enrollment

Conditions

Long QT Syndrome

Interventions

Wearable deviceDEVICE

This is an observational study that does not impact routine clinical care for participants

Eligibility

Sex: ALLMin age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Clinical diagnosis of Long QT Syndrome * Aged 18 years or over * Phone with iOS version 15 or Android OS 9.0 or higher * Able and willing to provide informed consent Exclusion Criteria: * Unwilling or unable to give consent * Ventricular pacing at recruitment * Bundle branch block or pre-excitation at baseline

Locations (1)

Barts and London Hospital NHS Trust

London, United Kingdom

RECRUITING

Outcomes

Primary Outcomes

1. Determine the accuracy of repeated QT interval measurements using Fitbit-derived ECGs in patients with Long QT syndrome compared with the current standard (12-lead ECG and ambulatory monitors)

Time frame: From enrollment to 3 months

2. Establish intra-patient QT variability from weekly Fitbit-ECGs and frequency of measurements over 500ms.

Time frame: From enrollment to 3 months

Secondary Outcomes

1. Establish the utility of wearable devices for determining symptom aetiology in LQTS.

Time frame: From enrollment to 3 months

2. Develop pipelines for the analysis of ECG data collected remotely including use of in-house QT automated algorithms for future machine learning applications.

Time frame: From enrollment to 3 months

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.